than CFCs, preventing medication from reaching patients' airways.
-- HFA MDIs have different priming requirements. Priming (spraying
multiple doses into the air) loads the correct dose of medication
inside the inhaler. Each HFA inhaler has different priming
instructions, which can be quite different from CFC priming.
-- HFA MDIs offer more treatment options. In the past, all brand and
generic albuterol CFC MDIs were virtually identical. Now there are
three uniquely different formulations of albuterol HFA inhalers plus a
levalbuterol HFA inhaler -- each distinctly different from the others.
Some people may find that one HFA inhaler works better for them than
-- HFA MDIs cost more than generic CFC albuterol MDIs. HFA MDIs are not
simply copies of CFC MDIs with new propellants. The inhaler transition
required a complete overhaul of the MDI manufacturing process. No
generic HFA MDIs are currently available. This translates to higher
out-of-pocket expenses for many patients, even those with prescription
drug coverage. Pharmaceutical companies are providing financial
assistance to patients in the form of rebates, discounts and coupons
and patient assistance programs.
"These are lifesaving medications," says Sander. "Patients and medical
professionals need to know that inhalers are changing and have the
opportunity to make the switch in a medically responsible way. Our advice
to patients: Get the facts. Know your options. Make informed choices."
Visit AANMA's MDI Transition Web page at http://www.breatherville.org/MDITransition for more information.
Founded in 1985, Allergy & Asthma Network Mothers of Asthmatics is the
leading national non
|SOURCE Allergy & Asthma Network Mothers of Asthmatics|
Copyright©2008 PR Newswire.
All rights reserved